Overview

Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether VLY-686 can prevent or reduce the itch and dermatological reaction observed after healthy volunteers are injected with Substance P in comparison with placebo.
Phase:
Phase 1
Details
Lead Sponsor:
Vanda Pharmaceuticals
Treatments:
Neurokinin A
Substance P